DGX Form 144: Proposed sale of 10,000 shares

DGX filed a Form 144 reporting a proposed sale of 10,000 common shares through Fidelity Brokerage Services LLC.

Rhea-AI Filing Summary

DGX filed a Form 144 reporting a proposed sale of 10,000 common shares through Fidelity Brokerage Services LLC. The filing lists an aggregate value of $2,125,200.00, shows the figure 109,866,320, and is dated 03/02/2026 with NYSE noted.

Insights

Securities Compliance Analyst

Routine Form 144 notice of proposed sale; appears administrative rather than material.

The filing lists a proposed sale of 10,000 common shares via Fidelity Brokerage Services LLC and an aggregate amount of $2,125,200.00. The entry includes 109,866,320 as an additional reported figure and the exchange NYSE.

Form 144s notify the SEC of intended affiliate sales; this excerpt does not state whether the sale completed or the seller identity beyond the broker. Subsequent filings would show execution details.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the DGX Form 144 disclose?

The Form 144 discloses a proposed sale of 10,000 common shares through Fidelity Brokerage Services LLC. The filing lists an aggregate value of $2,125,200.00, the exchange NYSE, and the date 03/02/2026.

Who is the broker listed on the DGX Form 144?

The broker identified is Fidelity Brokerage Services LLC at 900 Salem Street, Smithfield, RI. The excerpt pairs that broker with the proposed sale of 10,000 common shares dated 03/02/2026.

How large is the proposed DGX sale in dollar terms?

The filing shows an aggregate amount of $2,125,200.00 adjacent to the 10,000-share line. The excerpt does not state whether this reflects proceeds, estimated value, or execution details beyond the listed figure.

Does the DGX excerpt state who is selling the shares?

The excerpt lists the broker and the proposed sale quantity but does not name an individual seller. It records the broker, share count, aggregate figure, exchange, and the date 03/02/2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/02/2026 - 02:21 PM EST Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001599837
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	QUEST DIAGNOSTICS INC
SEC File Number	001-12215
Address of Issuer	500 PLAZA DRIVE SECAUCUS NEW JERSEY 07094
Phone	9735202700
Name of Person for Whose Account the Securities are To Be Sold	Davis J. E.
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	10000	2125200.00	109866320	03/02/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/17/2023	Restricted Stock Vesting	Issuer			1182	02/17/2023	Compensation
Common	02/18/2023	Restricted Stock Vesting	Issuer			8452	02/18/2023	Compensation
Common	02/24/2023	Restricted Stock Vesting	Issuer			366	02/24/2023	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	03/02/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	08/26/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Adam Gehring, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for James E. Davis
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)